Cost Plus Drug Company Sparks Moves To Change How Rx Drugs Are Priced

Mark Cuban’s direct-to-consumer venture, the Cost Plus Drug company, continues to disrupt generic pharmaceutical pricing. And as traditional pharmacy benefit managers come under increasing pressure to deliver more transparent pricing and lower costs to their clients, they’re responding with novel cost-based pricing and reimbursement models. However, unlike CPD these models aren’t…